192 related articles for article (PubMed ID: 8962127)
1. Melanoma angiogenesis and metastasis modulated by ribozyme targeting of the secreted growth factor pleiotrophin.
Czubayko F; Schulte AM; Berchem GJ; Wellstein A
Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14753-8. PubMed ID: 8962127
[TBL] [Abstract][Full Text] [Related]
2. Ribozyme targeting of the growth factor pleiotrophin in established tumors: a gene therapy approach.
Malerczyk C; Schulte AM; Czubayko F; Bellon L; Macejak D; Riegel AT; Wellstein A
Gene Ther; 2005 Feb; 12(4):339-46. PubMed ID: 15496960
[TBL] [Abstract][Full Text] [Related]
3. Ribozyme-targeting elucidates a direct role of pleiotrophin in tumor growth.
Czubayko F; Riegel AT; Wellstein A
J Biol Chem; 1994 Aug; 269(33):21358-63. PubMed ID: 8063762
[TBL] [Abstract][Full Text] [Related]
4. Ribozyme-targeting reveals the rate-limiting role of pleiotrophin in glioblastoma.
Grzelinski M; Bader N; Czubayko F; Aigner A
Int J Cancer; 2005 Dec; 117(6):942-51. PubMed ID: 15986444
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic silence of pleiotrophin by targeted delivery of siRNA and its effect on the inhibition of tumor growth and metastasis.
Zha L; He L; Xie W; Cheng J; Li T; Mohsen MO; Lei F; Storni F; Bachmann M; Chen H; Zhang Y
PLoS One; 2017; 12(5):e0177964. PubMed ID: 28562667
[TBL] [Abstract][Full Text] [Related]
6. Pleiotrophin can be rate-limiting for pancreatic cancer cell growth.
Weber D; Klomp HJ; Czubayko F; Wellstein A; Juhl H
Cancer Res; 2000 Sep; 60(18):5284-8. PubMed ID: 11016659
[TBL] [Abstract][Full Text] [Related]
7. The potential role of the heparin-binding growth factor pleiotrophin in breast cancer.
Riegel AT; Wellstein A
Breast Cancer Res Treat; 1994; 31(2-3):309-14. PubMed ID: 7533562
[TBL] [Abstract][Full Text] [Related]
8. Identification of the angiogenesis signaling domain in pleiotrophin defines a mechanism of the angiogenic switch.
Zhang N; Zhong R; Perez-Pinera P; Herradon G; Ezquerra L; Wang ZY; Deuel TF
Biochem Biophys Res Commun; 2006 May; 343(2):653-8. PubMed ID: 16554021
[TBL] [Abstract][Full Text] [Related]
9. Heparanase gene silencing, tumor invasiveness, angiogenesis, and metastasis.
Edovitsky E; Elkin M; Zcharia E; Peretz T; Vlodavsky I
J Natl Cancer Inst; 2004 Aug; 96(16):1219-30. PubMed ID: 15316057
[TBL] [Abstract][Full Text] [Related]
10. Enhanced antitumorigenic effects in glioblastoma on double targeting of pleiotrophin and its receptor ALK.
Grzelinski M; Steinberg F; Martens T; Czubayko F; Lamszus K; Aigner A
Neoplasia; 2009 Feb; 11(2):145-56. PubMed ID: 19177199
[TBL] [Abstract][Full Text] [Related]
11. Delivery of unmodified bioactive ribozymes by an RNA-stabilizing polyethylenimine (LMW-PEI) efficiently down-regulates gene expression.
Aigner A; Fischer D; Merdan T; Brus C; Kissel T; Czubayko F
Gene Ther; 2002 Dec; 9(24):1700-7. PubMed ID: 12457284
[TBL] [Abstract][Full Text] [Related]
12. [A pleiotrophin-specific siRNA and its effect on PTEN-/- MEF241 cells].
Hu YC; Liu ML; Li G; Huo YY; Wu DC
Ai Zheng; 2006 Oct; 25(10):1210-5. PubMed ID: 17059762
[TBL] [Abstract][Full Text] [Related]
13. Human trophoblast and choriocarcinoma expression of the growth factor pleiotrophin attributable to germ-line insertion of an endogenous retrovirus.
Schulte AM; Lai S; Kurtz A; Czubayko F; Riegel AT; Wellstein A
Proc Natl Acad Sci U S A; 1996 Dec; 93(25):14759-64. PubMed ID: 8962128
[TBL] [Abstract][Full Text] [Related]
14. Pleiotrophin, an angiogenic and mitogenic growth factor, is expressed in human gliomas.
Mentlein R; Held-Feindt J
J Neurochem; 2002 Nov; 83(4):747-53. PubMed ID: 12421346
[TBL] [Abstract][Full Text] [Related]
15. A secreted FGF-binding protein can serve as the angiogenic switch in human cancer.
Czubayko F; Liaudet-Coopman ED; Aigner A; Tuveson AT; Berchem GJ; Wellstein A
Nat Med; 1997 Oct; 3(10):1137-40. PubMed ID: 9334727
[TBL] [Abstract][Full Text] [Related]
16. Human breast cancer growth inhibited in vivo by a dominant negative pleiotrophin mutant.
Zhang N; Zhong R; Wang ZY; Deuel TF
J Biol Chem; 1997 Jul; 272(27):16733-6. PubMed ID: 9201975
[TBL] [Abstract][Full Text] [Related]
17. An antisense strategy for inhibition of human melanoma growth targets the growth factor pleiotrophin.
Satyamoorthy K; Oka M; Herlyn M
Pigment Cell Res; 2000; 13 Suppl 8():87-93. PubMed ID: 11041363
[TBL] [Abstract][Full Text] [Related]
18. Pleiotrophin, a multifunctional tumor promoter through induction of tumor angiogenesis, remodeling of the tumor microenvironment, and activation of stromal fibroblasts.
Perez-Pinera P; Chang Y; Deuel TF
Cell Cycle; 2007 Dec; 6(23):2877-83. PubMed ID: 18156802
[TBL] [Abstract][Full Text] [Related]
19. Implications of pleiotrophin in human PC3 prostate cancer cell growth in vivo.
Tsirmoula S; Dimas K; Hatziapostolou M; Lamprou M; Ravazoula P; Papadimitriou E
Cancer Sci; 2012 Oct; 103(10):1826-32. PubMed ID: 22783964
[TBL] [Abstract][Full Text] [Related]
20. Pleiotrophin expression in astrocytic and oligodendroglial tumors and it's correlation with histological diagnosis, microvascular density, cellular proliferation and overall survival.
Peria FM; Neder L; Marie SK; Rosemberg S; Oba-Shinjo SM; Colli BO; Gabbai AA; Malheiros SM; Zago MA; Panepucci RA; Moreira-Filho CA; Okamoto OK; Carlotti CG
J Neurooncol; 2007 Sep; 84(3):255-61. PubMed ID: 17443289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
